Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

September 18, 2024

Study Completion Date

July 28, 2025

Conditions

MenopauseEstrogen DeficiencyWomenAging

Interventions

DRUG

GnRH antagonist

GnRH antagonist will be given once for premenopausal women (12-week intervention) and twice for postmenopausal women (24-week intervention)

Trial Locations (1)

University of Colorado Denver Anschutz Medical Campus, Aurora

All Listed Sponsors

lead

University of Colorado, Denver

OTHER